Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853)

被引:78
作者
Mullin, S [1 ]
Mani, N [1 ]
Grossman, TH [1 ]
机构
[1] Vertex Pharmaceut, Cambridge, MA 02139 USA
关键词
D O I
10.1128/AAC.48.11.4171-4176.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inhibitors of mammalian multidrug efflux, such as the plant alkaloid reserpine, are also active in potentiating antibiotic activity by inhibiting bacterial efflux. Based on this precedent, two novel mammalian multiple drug resistance inhibitors, biricodar (VX-710) and timcodar (VX-853), were evaluated for activity in a variety of bacteria. Both VX-710 and VX-853 potentiated the activity of ethidium bromide (EtBr), a model efflux substrate, against three clinically significant gram-positive pathogens: Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pneumoniae. Similar to reserpine, VX-710 and VX-853 directly blocked EtBr efflux in S. aureus. Furthermore, these compounds were effective in lowering the MICs of several clinically used antibiotics, including fluoroquinolones, suggesting that VX-710 and VX-853 are representatives of a new class of bacterial efflux inhibitors with the potential for use in combination therapy.
引用
收藏
页码:4171 / 4176
页数:6
相关论文
共 37 条
  • [1] Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus
    Aeschlimann, JR
    Dresser, LD
    Kaatz, GW
    Rybak, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 335 - 340
  • [2] [Anonymous], 2000, M7A5 NAT COMM CLIN L, pM7
  • [3] Barrett J F, 2001, Curr Opin Investig Drugs, V2, P212
  • [4] Bellido JLM, 2002, REV MED MICROBIOL, V13, P1
  • [5] Bramwell VHC, 2002, CLIN CANCER RES, V8, P383
  • [6] Cellular and biochemical characterization of VX-710 as a chemosensitizer: Reversal of P-glycoprotein-mediated multidrug resistance in vitro
    Germann, UA
    Shlyakhter, D
    Mason, VS
    Zelle, RE
    Duffy, JP
    Galullo, V
    Armistead, DM
    Saunders, JO
    Boger, J
    Harding, MW
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 125 - 140
  • [7] Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
    Germann, UA
    Ford, PJ
    Shlyakhter, D
    Mason, VS
    Harding, MW
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 141 - 155
  • [8] GERMANN UA, 1996, P 87 ANN M AM ASS CA, V37
  • [9] A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus
    Gibbons, S
    Oluwatuyi, M
    Kaatz, GW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 13 - 17
  • [10] Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae
    Gill, MJ
    Brenwald, NP
    Wise, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 187 - 189